Related Experiment Video
Updated: Oct 12, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGFβ-induced expression of long noncoding lincRNA Platr18 controls breast cancer axonogenesis
Simon Grelet1,2,3,4, Cécile Fréreux4, Clémence Obellianne5
1Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, USA sgrelet@southalabama.edu.
Abstract:
Metastasis is the leading driver of cancer-related death. Tumor cell plasticity associated with the epithelial-mesenchymal transition (EMT), an embryonic program also observed in carcinomas, has been proposed to explain the colonization of distant organs by the primary tumor cells. Many studies have established correlations between EMT marker expression in the primary tumor and metastasis in vivo. However, the longstanding model of EMT-transitioned cells disseminating to secondary sites is still actively debated and hybrid states are presently considered as more relevant during tumor progression and metastasis. Here, we describe an unexplored role of EMT on the tumor microenvironment by controlling tumor innervation. Using in vitro and in vivo breast tumor progression models, we demonstrate that TGFβ-mediated tumor cell EMT triggers the expression of the embryonic LincRNA Platr18 those elevated expression controls the expression of the axon guidance protein semaphorin-4F and other neuron-related molecules such as IGSF11/VSIG-3. Platr18/Sema4F axis silencing abrogates axonogenesis and attenuates metastasis. Our observations suggest that EMT-transitioned cells are also locally required in the primary tumor to support distant dissemination by promoting axonogenesis, a biological process known for its role in metastatic progression of breast cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
